MTEM Insider Trading
Insider Ownership Percentage: 13.90%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $844,681.20
Molecular Templates Insider Trading History Chart
This chart shows the insider buying and selling history at Molecular Templates by year and by quarter.
Skip ChartChart Data in Insider Trading History Table
Molecular Templates Share Price & Price History
Current Price: $0.00
Price Change: ▼ Price Decrease of -0.0001 (-50.00%)
As of 04/3/2025 10:30 AM ET
Molecular Templates Insider Trading History
Molecular Templates Institutional Trading History
Data available starting January 2016
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases in the United States. The company develops therapies through its proprietary biologic drug platform technology (ETB). It is also developing MT- 8421, an ETB candidate that is in Phase I clinical trial for the treatment of dismantling TME through direct cell-kill of tumor and immune cell; MT-0169, which is in Phase I clinical trial to treat relapsed/refractory multiple myeloma; and MT-6402 in that is in Phase I clinical trial for relapsed/refractory patients with PD-L1 expressing tumors. The company has a collaboration agreement with Bristol Myers Squibb to discover and develop novel products containing ETBs directed to multiple targets. Molecular Templates, Inc. was founded in 2001 and is headquartered in Austin, Texas.
Read More on Molecular Templates
Volume
520 shs
Average Volume
4,039,411 shs
Market Capitalization
$658.40
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.22
Who are the company insiders with the largest holdings of Molecular Templates?